National Oral Cancer Month: Early Detection Saves Lives
April is Oral Cancer Awareness Month – an opportunity to raise awareness about the serious and deadly effects of this cancer. Nearly 58,500 Americans will be diagnosed with oral or oropharyngeal cancer this year.
Survivors like Steve Westphal understand the significance of early detection and prevention. In 2018, Steve was diagnosed with oral cancer, which marked the beginning of a long journey toward recovery. Following several surgeries, months spent in and out of the hospital, radiation treatments, and even a brief placement in hospice care, Steve was able to return home in 2020 and was declared cleared with no evidence of disease (NED).
Steve’s resilience inspired him to join Right Scan Right Time in advocating for proper reimbursement policies for AI-driven cancer imaging technologies. Thanks to advocacy from Steve and others, lawmakers recently introduced the Health Tech Investment Act (HTIA), which would ensure a stable payment pathway for AI-enabled medical devices. These devices can help physicians detect oral and other types of cancer at earlier, more preventable stages.
We encourage you to learn more about your screening options and join Steve in taking action to advance the Health Tech Investment Act.
More Articles
Focused Ultrasound Advocates Visit Capitol Hill
Recently, the Medical Imaging & Technology Alliance (MITA) joined with the Focused Ultrasound Foundation to host a group…
Read MoreThis National Minority Health Month, Support the FIND Act to Expand Access to Innovative Diagnostics
Bipartisan Bill Would Help Address Disparities in Alzheimer’s and Parkinson’s Disease, Breast and Prostate Cancer Recognized every year…
Read MoreAdvocates Across the Country Speak Out Against Medicare Cuts
These pandemic years have been challenging, especially for doctors, who have worked to adapt, treat, and lead us…
Read MoreHow Focused Ultrasound Helped One Patient Treat His Prostate Cancer
When Michael Swann turned 60, his urologist explained the importance of monitoring prostate-specific antigen (PSA) levels as an…
Read More